Abstract This study aims to assess the impact of upfront double-guidewire technique (DGT) following inadvertent early pancreatic duct (PD) cannulation or biliary cannulation and post-endoscopic retrograde cholangiopancreatography (ERCP) complications. A pilot non-randomized cohort study was performed in patients undergoing ERCP. DGT was utilized in the first 25 patients followed by standard cannulation technique (SCT) in the subsequent 25. A significantly lower PD cannulation rate [median (range)] was noted in the DGT group [1 (0-5) vs. 3 (0-6); p=0.013]; however, the pancreatitis rate was similar [2 (9 %) DGT, 1 (4 %) SCT; p=0.601]. In the SCT group, 15/25 (60 %) required DGT to achieve biliary cannulation. The majority of our cohort proceeding to an SCT following early PD cannulation required a DGT to achieve biliary cannulation. Early DGT resulted in a significant reduction in unintentional pancreatic cannulation but did not translate into a reduction in pancreatitis in our cohort.
Introduction
Endoscopic retrograde cholangiopancreatography (ERCP) is a key treatment modality in biliary diseases [1] . However, even in experienced hands biliary cannulation remains challenging [2, 3] . Dumonceau et al. first described the double-guidewire technique (DGT) in difficult biliary cannulation [4] . DGT involves the insertion of a pancreatic guidewire, which occupies the duct and straightens out the biliary and pancreatic ducts [5, 6] . A cannulation device is placed in the papilla above the pancreatic wire, assisting biliary cannulation [1, 6] . Maeda et al. showed that DGT was superior to standard cannulation technique (SCT) in difficult biliary cannulation [7] ; however, a subsequent randomized controlled trial rejected these findings [1] . No data exists on upfront DGT following early inadvertent pancreatic duct (PD) cannulation and its impact on biliary cannulation rates and post-procedure complications compared to SCT.
Materials and Methods
A pilot non-randomized cohort study was conducted from May 2010 to August 2011 at Austin Health in Victoria, Australia. Consecutive patients with native papillae undergoing ERCP were eligible for recruitment. Inclusion criteria were age ≥18 years, has undergone inadvertent PD cannulation within the first five attempts at biliary cannulation, and the procedure has been performed by the study endoscopist. Exclusion criteria were previous sphincterotomy or balloon dilatation of the biliary sphincter and previous biliary or pancreatic stent insertion.
A single consultant endoscopist (MN) was involved in this study. Data were collected prospectively with the institutional review board's ethical approval.
Design and definitions
Common bile duct (CBD) cannulation was attempted in all cases by a guidewire technique. The start of the cannulation attempt was defined when the cannulatome was inserted into the ampullary orifice and ceased when disengagement from the ampulla occurred. Enrolment of patients occurred if the pancreas was inadvertently cannulated with the wire during the first five attempts of biliary cannulation. The first 25 patients in our study proceeded to upfront DGT with the subsequent 25 patients continuing with SCT after pancreatic wire removal.
In the upfront DGT group, the PD wire was left in place and no contrast was injected (step 1). A cannulatome exchange was performed (step 2). The second wireloaded cannulatome was positioned at the ampullary orifice above the pancreatic wire in the direction of the CBD and ten attempts at cannulation were undertaken (step 3).
If CBD cannulation was not successful, a pancreatic stent was inserted (step 4). Further ten attempts were then made at cannulation (step 5). If failure of CBD access occurred, the endoscopist proceeded to precut sphincterotomy (PS) (step 6).
In the SCT group after initial inadvertent pancreatic wire cannulation, the wire was removed and ten attempts at CBD cannulation were performed. If unsuccessful, the endoscopist would proceed to intentional pancreatic cannulation and the DGT route as previously described in steps 1 to 6. Flowchart of the study design is illustrated in Fig. 1 .
Outcome measures
The primary end-point was the successful cannulation of the CBD (Fig. 2) . Secondary end-points included procedural 
Statistical analysis
Descriptive statistics were utilized to describe patient characteristics, which were presented as means and standard deviations. Continuous variables were compared with the Mann-Whitney test, whereas categorical variables were analyzed with the chi-square and Fisher's exact test. Statistical analysis was performed by using SPSS software (version 19.0; SPS Inc, Chicago IL, USA). Sample size calculations were not performed as this was an observational pilot study and from our calculations, in order to detect a 50 % decrease in pancreatitis rates (8 % to 4 %) alone between DGT and SCT, we would require 500 patients in each study arm which was not feasible at our institution.
Results
In total, 300 patients underwent ERCP during the study period. Fifty (17 %) patients fulfilled the inclusion criteria and were enrolled. Two patients were excluded from DGT group due to equipment failure. The SCT and DGT groups were comparable across demographics, comorbidities, and ERCP indications ( Table 1 ). The only significant difference was a higher proportion of patients with a lower American Society of Anesthesiologists (ASA) classification in the DGT group [1 (0-5) vs. 3 (0-6); p=0.013].
All patients achieved CBD cannulation. However, 15 (60 %) patients in the SCT group failed initially to gain biliary access and proceeded to DGT to gain CBD cannulation (Table 2) . Nine (36 %) of these patients gained CBD cannulation by DGT alone and six (24 %) combined with PD stenting.
The mean time of successful CBD cannulation was 12 min in DGT and 20 min in the SCT group; however, this difference was not statistically significant (p=0.433). There were similar rates of pancreatic stenting across both groups [6 (24 %) SCT vs. 8 (35 %) DGT p=0.412)]. The requirement to proceed to PS was similar between the two groups [4 (16 %) SCT vs. 4 (17 %) DGT; p=0.897)] as seen in Table 2 . A significant difference in the number of repeated pancreatic cannulation was observed between the two groups in our study. The mean number of pancreatic cannulation was 1 in DGT vs. 3 in the SCT group, p=0.013. The number of patients with pancreatitis in post-ERCP was similar across the groups [1 (4 %) SCT vs. 2 (9 %) DGT; p=0.601] despite the significant reduction in PD cannulation in the DGT group. All cases were mild in nature. There were no significant differences in postprocedure bleeding (8 % SCT and 0 % DGT), cholangitis (4 % SCT and 9 % DGT), cholecystitis (4 % SCT and 0 % DGT), and 30-day mortality rate (4 % SCT and 4 % DGT). In both groups one death occurred following discharge from the hospital, which was related to cholangitis secondary to presumed biliary stent occlusion initially inserted for the indication of malignant biliary obstruction.
Discussion
Our pilot study was performed to assess biliary cannulation rates and post-ERCP complications with upfront DGT in comparison to SCT when early unintentional PD cannulation occurs. We found no significant difference in biliary cannulation rates between the two techniques. However, despite the global 100 % biliary cannulation rate in our cohort, the majority of the SCT group required subsequent reversion to DGT to achieve biliary cannulation. If we had not reverted to a DGT following failed standard cannulation attempts and utilized other biliary cannulation techniques, it is possible that our findings may have been different.
The DGT group had a substantially lower rate of PD cannulation in comparison to the SCT group. This difference was firstly due to ongoing inadvertent PD cannulation during attempts at CBD cannulation in the SCT group and secondly, a large proportion (60 %) in the SCT group required a subsequent DGT procedure. This did not translate into a difference in post-procedural pancreatitis. However, to detect a 50 % decrease in pancreatitis rates (8 % to 4 %) between DGT and SCT, we would require 500 patients in each study arm which was not feasible at our institution. The complication rates observed in our cohort reflected those published in the literature [1, 2, 8] .
The time period to successful biliary cannulation was higher in the SCT group compared to the DGT group; however, this did not achieve a statistical significance (20 and 12 min respectively; p=0.433). An 8-min time differential is substantial if we consider that 10 min has been used previously to classify difficult biliary cannulation [7] . The significance of prolonged ampullary orifice manipulation has been assessed as a risk factor for post-procedure pancreatitis [9] .
There were several limitations in our study, the main one being the small cohort size, which may have prevented detection of significant differences between the two groups. Second, a significant number of patients from the SCT group required the use of DGT to gain biliary access. Our protocol, however, allowed a direct comparison between the two techniques in early inadvertent PD cannulation. It has been increasingly advocated that endoscopists should proceed straight to a PS following failure of SCT [10] in order to avoid trauma to the papillae [8] , which was not examined in our study. In a recent RCT, DGT was comparable to PS for overall biliary cannulation, with DGT requiring a significantly shorter time to achieve biliary access [2] . The other point highlighted in their study was the rapid up-skilling in DGT whereas PS requires a substantial case volume to achieve an acceptable cannulation success rate [2, 8] . Reports suggest that PS has an increased complication rate over SCT even in the hands of experienced endoscopists [8, 11, 12] . DGT may therefore have a role in achieving biliary cannulation prior to PS. The strength of our study was the involvement of a single endoscopist with experience in the use of SCT, DGT, and PS, unlike other studies which included fellows with varying levels of expertise [1, 7] . We were therefore able to maintain a strict protocol for all patients involved.
In conclusion, for early unintentional PD cannulation, there was no clear advantage of DGT over SCT in biliary cannulation or post-procedure complications for our cohort. The lack of superiority of DGT over SCT may have been due to the crossover of patients from the SCT group to subsequent DGT to gain biliary access. Our pilot study is the first of its kind to review DGT against SCT in early unintentional PD cannulation. Further prospective RCTs are therefore required to investigate the utility of upfront DGT and its impact on biliary cannulation and post-ERCP complications. 
